
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systems Biological Analysis of Immune Response to Influenza Vaccination
Mario Cortese, Amy C Sherman, Nadine Rouphael, et al.
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 6, pp. a038596-a038596
Open Access | Times Cited: 17
Mario Cortese, Amy C Sherman, Nadine Rouphael, et al.
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 6, pp. a038596-a038596
Open Access | Times Cited: 17
Showing 17 citing articles:
System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans
Mario Cortese, Thomas Hagan, Nadine Rouphael, et al.
Nature Immunology (2025) Vol. 26, Iss. 1, pp. 116-130
Closed Access | Times Cited: 1
Mario Cortese, Thomas Hagan, Nadine Rouphael, et al.
Nature Immunology (2025) Vol. 26, Iss. 1, pp. 116-130
Closed Access | Times Cited: 1
The immunology of SARS-CoV-2 infections and vaccines
Lilit Grigoryan, Bali Pulendran
Seminars in Immunology (2020) Vol. 50, pp. 101422-101422
Open Access | Times Cited: 98
Lilit Grigoryan, Bali Pulendran
Seminars in Immunology (2020) Vol. 50, pp. 101422-101422
Open Access | Times Cited: 98
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
Tamás Fülöp, Anis Larbi, Graham Pawelec, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 607-607
Open Access | Times Cited: 38
Tamás Fülöp, Anis Larbi, Graham Pawelec, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 607-607
Open Access | Times Cited: 38
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future
Kristine A. Moore, Julie Ostrowsky, Alison M. Kraigsley, et al.
Vaccine (2021) Vol. 39, Iss. 45, pp. 6573-6584
Open Access | Times Cited: 52
Kristine A. Moore, Julie Ostrowsky, Alison M. Kraigsley, et al.
Vaccine (2021) Vol. 39, Iss. 45, pp. 6573-6584
Open Access | Times Cited: 52
Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?
Per Johan Klasse, Gabriel Ozorowski, Rogier W. Sanders, et al.
Cell Host & Microbe (2020) Vol. 27, Iss. 4, pp. 507-518
Open Access | Times Cited: 50
Per Johan Klasse, Gabriel Ozorowski, Rogier W. Sanders, et al.
Cell Host & Microbe (2020) Vol. 27, Iss. 4, pp. 507-518
Open Access | Times Cited: 50
The role of cell-mediated immunity against influenza and its implications for vaccine evaluation
Yorick Janssens, Jasper Joye, Gwenn Waerlop, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Yorick Janssens, Jasper Joye, Gwenn Waerlop, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Delay of innate immune responses following influenza B virus infection affects the development of a robust antibody response in ferrets
Thomas Rowe, A. Fletcher, Melissa Lange, et al.
mBio (2025)
Open Access
Thomas Rowe, A. Fletcher, Melissa Lange, et al.
mBio (2025)
Open Access
The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development
Cong Sun, Xinchun Chen, Yinfeng Kang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 33
Cong Sun, Xinchun Chen, Yinfeng Kang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 33
Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation
Virgil E.J.C. Schijns, Dragomira Majhen, Peter van der Ley, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 501-501
Open Access | Times Cited: 30
Virgil E.J.C. Schijns, Dragomira Majhen, Peter van der Ley, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 501-501
Open Access | Times Cited: 30
The effect of influenza vaccine in reducing the severity of clinical outcomes in patients with COVID-19: a systematic review and meta-analysis
Hossam Waleed Almadhoon, Aboalmagd Hamdallah, Sarah Makram Elsayed, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Hossam Waleed Almadhoon, Aboalmagd Hamdallah, Sarah Makram Elsayed, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly
Peggy Riese, Stephanie Trittel, Manas K. Akmatov, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Peggy Riese, Stephanie Trittel, Manas K. Akmatov, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction
Jing Cai, Bo‐Dou Zhang, Yuqi Li, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1290-1290
Open Access | Times Cited: 17
Jing Cai, Bo‐Dou Zhang, Yuqi Li, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1290-1290
Open Access | Times Cited: 17
The Relationship between Immunogenicity and Reactogenicity of Seasonal Influenza Vaccine Using Different Delivery Methods
Daniel Gromer, Brian D. Plikaytis, Michele Paine McCullough, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 809-809
Open Access
Daniel Gromer, Brian D. Plikaytis, Michele Paine McCullough, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 809-809
Open Access
Leveraging Pre-Vaccination Antibody Titers across Multiple Influenza H3N2 Variants to Forecast the Post-Vaccination Response
Hannah D. Stacey, Michael A. Carlock, James D. Allen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Hannah D. Stacey, Michael A. Carlock, James D. Allen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Dynamics and implications of anti-drug antibodies against adalimumab using ultra-sensitive and highly drug-tolerant assays
Xiaoliang Ding, Ling Xue, Mingjun Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Xiaoliang Ding, Ling Xue, Mingjun Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Vaccine Immunology
Claire‐Anne Siegrist, Christiane S. Eberhardt
Elsevier eBooks (2023), pp. 17-36.e7
Closed Access | Times Cited: 1
Claire‐Anne Siegrist, Christiane S. Eberhardt
Elsevier eBooks (2023), pp. 17-36.e7
Closed Access | Times Cited: 1
Cytoplasmic Sensing in Innate Immunity
Ajay Suresh Akhade, Naeha Subramanian
Elsevier eBooks (2022), pp. 624-643
Closed Access
Ajay Suresh Akhade, Naeha Subramanian
Elsevier eBooks (2022), pp. 624-643
Closed Access